https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730950 Fri, 08 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730950-fda-clears-ind-for-harbour-biomeds-hbm-7004 http://www.bioworld.com/articles/730921 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730921-how-to-summit-up-dis-harmoni-on-ivonescimab-nsclc-phase-iii Xray showing lung cancer on tablet http://www.bioworld.com/articles/730879 Tue, 05 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730879-cytospire-raises-61m-series-a-to-target-egfr-in-solid-tumors The epidermal growth factor receptor in the inactive (left) and active (right) form. The epidermal growth factor receptor in the inactive (left) and active (right) form. http://www.bioworld.com/articles/730767 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730767-how-to-summit-up-dis-harmoni-on-ivonescimab-nsclc-phase-iii Xray showing lung cancer on tablet http://www.bioworld.com/articles/730786 Tue, 28 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730786-akeso-sets-durability-bar-as-immuno-oncology-20-race-heats-up Pancreas anatomy illustration http://www.bioworld.com/articles/730640 Mon, 27 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730640-s-os-compass-phase-ii-iii-biliary-data-mixed-ahoy-fda Illustration of cancer in the bile ducts http://www.bioworld.com/articles/730634 Fri, 24 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730634-seed-funding-at-ferrosa-therapeutics Coins and seedling http://www.bioworld.com/articles/730586 Thu, 23 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730586-inca-036873-appears-to-be-potent-in-cd70-expressing-cancer 3d rendering of bispecific antibodies http://www.bioworld.com/articles/730500 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730500-akeso-sets-durability-bar-as-immuno-oncology-20-race-heats-up Pancreas anatomy illustration http://www.bioworld.com/articles/730557 Wed, 22 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730557-elpisciences-bispecific-antibody-es-302-reduces-disease-activity-in-ibd-model Illustration of intestinal track http://www.bioworld.com/articles/730486 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730486-early-data-position-junshi-in-next-gen-immuno-oncology-race Illustration of cancer cells and immunotherapy treatment http://www.bioworld.com/articles/730428 Thu, 16 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730428-chinas-nmpa-accepts-mabwells-ind-application-for-6mw5311 Microscopic image of acute myeloid leukemia (AML) cells. Acute myeloid leukemia cells. Credit: Cincinnati Children's http://www.bioworld.com/articles/730275 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730275-sidewinders-bispecific-adc-approach-draws-137m-series-b Blue digital dollar sign http://www.bioworld.com/articles/730148 Wed, 08 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730148-sidewinders-bispecific-adc-approach-draws-137m-series-b Blue digital dollar sign http://www.bioworld.com/articles/730188 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730188-fortitude-unveils-lead-program-for-axial-spondyloarthritis Spinal cord http://www.bioworld.com/articles/729964 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729964-galapagos-enters-new-era-as-lakefront-after-reshaping-gilead-alliance Handshake icon engraved on metal hexagonal background http://www.bioworld.com/articles/730040 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730040-hxn-1023-drives-robust-anti-inflammatory-responses-in-atopic-dermatitis-models Skin, tissue layer illustration http://www.bioworld.com/articles/730036 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730036-nav-242-bispecific-antibody-supports-quarterly-dosing-in-hs http://www.bioworld.com/articles/729995 Fri, 27 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729995-more-than-two-to-tango-multispecifics-at-esmo-tat Antibodies artwork http://www.bioworld.com/articles/729930 Thu, 26 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729930-multibody-tev325-achieves-preclinical-milestone Illustration of a road with three destination markers http://www.bioworld.com/articles/729898 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729898-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729897 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729897-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729895 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729895-simceres-pd-l1-il-15-bispecific-sees-early-edge-in-bladder-cancer Bladder cancer illustration http://www.bioworld.com/articles/729812 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729812-laigo-extends-seed-round-as-targeted-protein-degradation-field-gathers-pace White Euro symbol on blue background http://www.bioworld.com/articles/729763 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729763-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729788 Thu, 19 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729788-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729564 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729564-simceres-pd-l1-il-15-bispecific-sees-early-edge-in-bladder-cancer Bladder cancer illustration http://www.bioworld.com/articles/729560 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729560-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729715 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729715-kanaphs-27m-ipo-to-aid-multi-modality-cancer-immune-portfolio Lee Byoung-chul, CEO, Kanaph Kanaph CEO Lee Byoung-chul at the company's IPO ceremony. http://www.bioworld.com/articles/729714 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729714-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics